The United States Vascular and Endovascular Monitor (USVEM) is used to provide a measure of device usage across Europe and is especially good at revealing trends in the Vascular and Endovascular market.
We produce market reports in a quarterly format through the use of a panel of 200 centres across the United States.
Clients use the monitor to obtain key market, customer and sales information when they need it. Through a USVEM subscription clients can:
Abdominal aortic aneurysms (AAA)
- Monitors the endovascular device market dealing in treating abdominal aortic aneurysms
- Measure consumption/device usage and see accurate market share information for each leading brand.
- Track device average selling prices (ASPs) on a quarterly basis
Thoracic aortic aneurysms (TAA)
- Monitors the endovascular device market dealing in treating thoracic aortic aneurysms
- Measure consumption/device usage and see accurate market share information for each leading brand.
- Track device average selling prices (ASPs) on a quarterly basis
Reports
- AAA report United States ,(in-depth quarterly and historical analysis)
- AAA United States Executive Summary (compacted)
- TAA report United States,(in-depth quarterly and historical analysis)
- TAA United States Executive summary
- Executive Summary (quarterly overview)
- Database/Pivot table format
- Ad-hoc documents upon request
The USVEM methodology
The USVEM methodology consists of a consumption-based panel formed of Physicians from over 200 hospitals across Europe. All the hospitals are medium and high-volume centres. Data is received on a quarterly basis from Panel members and represents the whole hospital. Data is gathered through questionnaires specifically designed, through ongoing telephone interviews and 1-to-1 meetings at conferences.
Data from the Panel show changes in clinical practices and are a reliable indication of the most used technologies. However, in order to determine exact market share and turnover figures, our analysis model takes in account 11 other factors. These factors are (in alphabetical order):
- Brand reputation
- CE approval / National guidelines & protocols / reimbursement
- Corporate financial results
- Innovation
- Marketing campaigns
- Media impact
- Portfolio
- Pricing
- Product penetration rate
- Sales force
- Trends
The final data are cross-referenced with public registries and with sales figures from industry partners. The composition of our research Panel is stable: this allows us to appreciate changes in clinical practice, as well as in the use of technologies over a certain period of time. One-off questionnaires at meetings are used to validate the main findings from the report.
Market demographic coverage
The study examines the market in California, Texas and Florida. It then concentrates on the Mid-West states (Wisconsin, Illinois, Indiana, Ohio & Michigan) and North East States (Maine, Vermont, New Hampshire, Massachusetts, Rhode Island, Connecticut, New York, New Jersey and Pennsylvania)
